Cancer Research Cancer Research Funding Available  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 1478-1482, April 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, E. G.
Right arrow Articles by Burns, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, E. G.
Right arrow Articles by Burns, H., Jr.

N-Nitrosodimethylamine Carcinogenesis in Nicotinamide-deficient Rats1

Edward G. Miller2 and Henry Burns, Jr.

Department of Biochemistry, Baylor College of Dentistry, Dellas, Texas 75246

Special diets that were extremely low in protein (5.5%) and high in carbohydrate were used to test the effect of nicotinamide on N-nitrosodimethylamine-induced carcinogenesis in Holtzman albino rats. The level of nicotinamide in the three diets ranged from 0 mg/kg of food to 50 mg/kg to 500 mg/kg. During the treatment with these diets (5 weeks) and the carcinogen (18 days), the renal and hepatic concentrations of nicotinamide adenine dinucleotide-reduced nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate-reduced nicotinamide adenine dinucleotide phosphate were measured. In the liver, the concentration of these coenzymes fell well below normal levels, and significant differences between the two extreme diets (0 and 500 mg/kg) were found in the hepatic content of nicotinamide adenine dinucleotide-reduced nicotinamide adenine dinucleotide. In the kidney, the treatment with special diets and carcinogen had less effect. The content of nicotinamide adenine dinucleotide phosphate-reduced nicotinamide adenine dinucleotide phosphate remained normal, and the only significant drop in the concentrations of nicotinamide adenine dinucleotide-reduced nicotinamide adenine dinucleotide phosphate occurred in the animals on the nicotinamide-deficient diet.

After the treatment, all of the animals were returned to the same standard diet. During the remainder of the experiment, 85 weeks, it was found that the initial treatments had not affected tumor incidence levels or tumor type, but had altered the rate of tumor incidence. These differences could be seen by comparing the results for the rats that had been given the nicotinamide-deficient diet to the results for the animals receiving an excess of the vitamin.

1 This study was supported by Baylor College of Dentistry Research Funds.

2 To whom requests for reprints should be addressed.

Received 12/12/82. Accepted 1/ 6/84.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.